| Literature DB >> 36182970 |
Francesca Battaglin1, Priya Jayachandran1, Carly Strelez2, Annika Lenz1, Sandra Algaze1, Shivani Soni1, Jae Ho Lo1, Yan Yang3, Joshua Millstein3, Wu Zhang1, Evanthia T Roussos Torres1, Jean C Shih4, Shannon M Mumenthaler1,2,5, Josh Neman6, Heinz-Josef Lenz7.
Abstract
The brain-gut axis, a bidirectional network between the central and enteric nervous system, plays a critical role in modulating the gastrointestinal tract function and homeostasis. Recently, increasing evidence suggests that neuronal signaling molecules can promote gastrointestinal cancers, however, the mechanisms remain unclear. Aberrant expression of neurotransmitter signaling genes in colorectal cancer supports the role of neurotransmitters to stimulate tumor growth and metastatic spread by promoting cell proliferation, migration, invasion, and angiogenesis. In addition, neurotransmitters can interact with immune and endothelial cells in the tumor microenvironment to promote inflammation and tumor progression. As such, pharmacological targeting of neurotransmitter signaling represent a promising novel anticancer approach. Here, we present an overview of the current evidence supporting the role of neurotransmitters in colorectal cancer biology and treatment.Entities:
Year: 2022 PMID: 36182970 DOI: 10.1038/s41388-022-02479-4
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 8.756